Karyotyping plays a significant role in cancer diagnosis and management. Many cancers exhibit specific chromosomal abnormalities, such as translocations, deletions, duplications, or aneuploidy. Identifying these abnormalities can help in diagnosing the type of cancer, guiding treatment decisions, and predicting prognosis. For instance, the presence of the Philadelphia chromosome due to a translocation between chromosomes 9 and 22 is a hallmark of chronic myeloid leukemia (CML).
